R. Jiménez-Puya

发表

Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry

F. Vanaclocha, I. García-Doval, J. Carrascosa, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry

I. García-Doval, J. Carrascosa, I. Belinchón, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Etanercept: Efficacy and safety

R. Jiménez-Puya, F. Gómez-García, V. Amorrich-Campos, 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

Obesity and Psoriasis: Inflammatory Nature of Obesity, Relationship Between Psoriasis and Obesity, and Therapeutic Implications

J. Carrascosa, R. Jiménez-Puya, R. Fernández-torres, 2014 .

[Sturge-Weber syndrome and type 1 neurofibromatosis: a chance association?].

R. Jiménez-Puya, J. Moreno-Giménez, A. Rodríguez-Bujaldón, 2008, Actas dermo-sifiliograficas.

[Treatment of chronic ulcers].

M. Galán-Gutiérrez, R. Jiménez-Puya, J. Moreno-Giménez, 2005, Actas dermo-sifiliograficas.

Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry

F. Vanaclocha, I. García-Doval, J. Carrascosa, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry

F. Vanaclocha, I. García-Doval, J. Carrascosa, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

Immune-Mediated Inflammatory Diseases and Other Comorbidities in Patients With Psoriasis: Baseline Characteristics of Patients in the AQUILES Study

F. Vanaclocha, J. Sánchez-Carazo, M. Ferran, 2015 .

[Acute acneform eruption secondary to cetuximab with good response to metronidazole].

R. Jiménez-Puya, F. Gómez-García, J. Moreno-Giménez, 2007, Actas dermo-sifiliograficas.

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry.

F. Vanaclocha, I. García-Doval, P. Dávila-Seijo, 2017, The Journal of investigative dermatology.

Immune-Mediated Inflammatory Diseases and Other Comorbidities in Patients With Psoriasis: Baseline Characteristics of Patients in the AQUILES Study

F. Vanaclocha, J. Sánchez-Carazo, M. Ferran, 2015 .

[Capecitabine-induced hyperpigmentation].

M. Galán-Gutiérrez, R. Jiménez-Puya, J. Moreno-Giménez, 2007, Actas dermo-sifiliograficas.

Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis

F. Vanaclocha, I. García-Doval, P. Dávila-Seijo, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Reticulohistiocitosis cutánea difusa

M. Galán, R. Jiménez-Puya, J. Moreno, 2006 .

Extensive Tinea in a Patient With Severe Combined Immunodeficiency

R. Jiménez-Puya, J. Moreno-Giménez, A. Rodríguez-Bujaldón, 2009, Pediatric dermatology.

[Proliferating pilomatricoma treated using a bilateral advancement flap].

R. Jiménez-Puya, F. Gómez-García, J. Moreno-Giménez, 2009, Actas dermo-sifiliograficas.

Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry.

F. Vanaclocha, M. Llamas-Velasco, J. Carrascosa, 2017, Actas dermo-sifiliograficas.

Renbök phenomenon in a patient with alopecia areata universalis.

R. Jiménez-Puya, J. Moreno-Giménez, A. García-Nieto, 2012, Archives of dermatology.

Dermatitis palmar vesiculoampollosa

R. Jiménez-Puya, M. Galán‐Gutiérrez, 2005 .

[Complications in dermatologic surgery].

R. Jiménez-Puya, F. Gómez-García, J. Moreno-Giménez, 2009, Actas dermo-sifiliograficas.

Long-Term Cost-Effectiveness Analysis of Etanercept and Adalimumab for Plaque Psoriasis not Associated with Arthritis

R. Jiménez-Puya, J. Moreno-Giménez, J. Ruano, 2013, Dermatology and Therapy.

Factors influencing seasonal patterns of relapse in anti‐TNF psoriatic responders after temporary drug discontinuation

R. Jiménez-Puya, J. Moreno-Giménez, J. Ruano, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[Trichothiodystrophy: PIBIDS syndrome].

R. Grimalt, R. Jiménez-Puya, J. Moreno-Giménez, 2007, Actas dermo-sifiliograficas.

LEOPARD syndrome: what are café noir spots?

M. Galán-Gutiérrez, R. Jiménez-Puya, J. Moreno-Giménez, 2008, Pediatric dermatology.

Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study.

F. Vanaclocha, J. Sánchez-Carazo, R. Jiménez-Puya, 2015, Actas dermo-sifiliograficas.

Body mass index in patients with moderate‐to‐severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry

F. Vanaclocha, I. García-Doval, G. Carretero, 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

Granulomatous Slack Skin Disease in a Child: The Outcome

M. Galán-Gutiérrez, R. Jiménez-Puya, F. Camacho, 2007, Pediatric dermatology.